Remove Heart Transplant Remove Quality of Life Remove Research
article thumbnail

Ochsner Children’s Hospital Advocates to Close the Gap in Pediatric Heart Care

DAIC

Getty Images milla1cf Wed, 02/21/2024 - 19:10 February 21, 2024 — Ochsner Children's Hospital , ranked among the top hospitals in the nation for pediatric cardiology and congenital heart surgery, is raising awareness of the need for more pediatric-specific heart devices. Yet, research and innovation in this field has not kept pace.

article thumbnail

Congenital Heart Defects: Helping Families Navigate the Challenges

MIBHS

Open-Heart Surgery : In cases where catheterization is not sufficient, open-heart surgery may be required to repair the defect. This involves opening the chest and heart to make the necessary repairs. Heart Transplant : In the most severe cases, where the heart is too damaged to be repaired, a heart transplant may be necessary.

article thumbnail

CVRx Announces Availability of Additional Data Supporting Long-term Benefits of Barostim

DAIC

Dr. JoAnn Lindenfeld of Vanderbilt University presented analysis showing that patients with Barostim + GDMT had sustained and significant improvements in quality-of-life scores (MLWHF and EQ-5D) and many subdomains of these scores (e.g., See more details at TCTMD. versus patients on GDMT alone.

article thumbnail

RELIEVE-HF Trial Outcomes Reported at ACC.24 Find Impact of Interatrial Shunt May Vary by Heart Failure Type

DAIC

While the trial did not meet its primary endpoint, it moves the field forward by offering signals that the benefits and risks of interatrial shunts may vary by heart failure type, according to researchers. Researchers tracked outcomes in each participant for at least one year and up to two years.

article thumbnail

Impact of Interatrial Shunt May Vary by Heart Failure Type

DAIC

While the trial did not meet its primary endpoint, it moves the field forward by offering signals that the benefits and risks of interatrial shunts may vary by heart failure type, according to researchers. Researchers tracked outcomes in each participant for at least one year and up to two years.

article thumbnail

BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study

DAIC

In the subgroup of patients targeted in the CardiAMP Heart Failure II Trial, results showed large absolute and relative risk reduction of heart death equivalents of the patients in the treated group. Treated patients also had reduced major adverse cardiac events and greatly improved quality of life. “We

CMS 111
article thumbnail

Published Research

Society of Thoracic Surgeons - Research

Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.